Notes from the Field: Posttreatment Lesions After Tecovirimat Treatment for Mpox — New York City, August–September 2022

Authors:
  • LSLeah Seifu
    Leah Seifu
  • EGElizabeth Garcia
    Elizabeth Garcia
  • TMTristan D. McPherson
    Tristan D. McPherson
  • MLMaura Lash
    Maura Lash
  • KAKaren A. Alroy
    Karen A. Alroy
  • MFMary Foote
    Mary Foote
  • ELEllen H. Lee
    Ellen H. Lee
  • JKJeffrey Kwong
    Jeffrey Kwong
  • ARAsa Radix
    Asa Radix
  • PRPaul Riska
    Paul Riska
  • JZJason Zucker
    Jason Zucker
  • SZSarah Zuercher
    Sarah Zuercher

Abstract
This report describes treatment of lesions following completion of tecovirimat therapy for mpox.